Todos Medical Launches Tollovid Daily™ via Subsc
Post# of 30028
(Total Views: 451)
Posted On: 09/23/2021 1:41:46 PM
Todos Medical Launches Tollovid Daily™ via Subscription at MyTollovid.com
Consumers can subscribe for an auto-shipped supply of Tollovid Daily™ 3CL protease inhibitor for immune support every month
New York, NY, and Tel Aviv, ISRAEL, Sept. 23, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- Todos Medical, Ltd. (“Todos Medical”) (OTCQB: TOMDF), a comprehensive medical diagnostics and related solutions company, announced an expansion of its Tollovid® dietary supplement 3CL protease (MPro) inhibitor immune support product line with the launch of Tollovid Daily™ via subscription. The subscription model takes the hassle out of remembering to order Tollovid Daily on a monthly basis.
Both Tollovid and Tollovid Daily are 3CL protease inhibitors for immune support that have 60 caplets per bottle. Tollovid Daily was designed as a twice-daily dosing schedule for people on the go that provides one month of daily immune support. Tollovid was designed as a 12 pills/day, 5-day dosing schedule for when a person is seeking maximum immune support over a short period of time.
“Tollovid Daily is an affordable immune support solution with mass market appeal,” said Gerald Commission CEO of Todos Medical. “We recently added the ability to accept payment via cryptocurrency on our www.MyTollovid.com e-commerce platform, and we think the Tollovid Daily subscription model appeals to consumers who are focused on automating their daily wellness routines. Our mission is to make our products available to anyone who wants them. We are making significant strides in making our products available via larger distribution channels, and we expect to provide further updates on this to the market shortly.”
https://investor.todosmedical.com/news-events...bscription
Consumers can subscribe for an auto-shipped supply of Tollovid Daily™ 3CL protease inhibitor for immune support every month
New York, NY, and Tel Aviv, ISRAEL, Sept. 23, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- Todos Medical, Ltd. (“Todos Medical”) (OTCQB: TOMDF), a comprehensive medical diagnostics and related solutions company, announced an expansion of its Tollovid® dietary supplement 3CL protease (MPro) inhibitor immune support product line with the launch of Tollovid Daily™ via subscription. The subscription model takes the hassle out of remembering to order Tollovid Daily on a monthly basis.
Both Tollovid and Tollovid Daily are 3CL protease inhibitors for immune support that have 60 caplets per bottle. Tollovid Daily was designed as a twice-daily dosing schedule for people on the go that provides one month of daily immune support. Tollovid was designed as a 12 pills/day, 5-day dosing schedule for when a person is seeking maximum immune support over a short period of time.
“Tollovid Daily is an affordable immune support solution with mass market appeal,” said Gerald Commission CEO of Todos Medical. “We recently added the ability to accept payment via cryptocurrency on our www.MyTollovid.com e-commerce platform, and we think the Tollovid Daily subscription model appeals to consumers who are focused on automating their daily wellness routines. Our mission is to make our products available to anyone who wants them. We are making significant strides in making our products available via larger distribution channels, and we expect to provide further updates on this to the market shortly.”
https://investor.todosmedical.com/news-events...bscription
(0)
(0)Amarantus Bioscience Holdings (AMBS) Stock Research Links
Scroll down for more posts ▼